New Key Statistics Module, Z-Score and F-Score
SZSE:301246 Key Ratios
Market Cap ¥ M | 5,948.10 |
Enterprise Value ¥ M | 4,631.14 |
P/E(ttm) | 228.77 |
PE Ratio without NRI | 89.04 |
Forward PE Ratio | -- |
Price/Book | 1.37 |
Price/Sales | 3.21 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.30 |
Revenue (TTM) ¥ M | 1,818.00 |
EPS (TTM) ¥ | 0.07 |
Beneish M-Score | -2.39 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 13.80 |
y-y EBITDA Growth Rate % | -80.30 |
EV-to-EBIT | 114.20 |
EV-to-EBITDA | 114.20 |
PEG | 6.45 |
Shares Outstanding M | 400.01 |
Net Margin (%) | 1.49 |
Operating Margin % | 2.93 |
Pre-tax Margin (%) | 1.59 |
Quick Ratio | 2.36 |
Current Ratio | 2.56 |
ROA % (ttm) | 0.47 |
ROE % (ttm) | 0.62 |
ROIC % (ttm) | 1.62 |
Dividend Yield % | 0.33 |
Altman Z-Score | 3.40 |
SZSE:301246 Number of Guru Trades
SZSE:301246 Volume of Guru Trades
Gurus Latest Trades with SZSE:301246
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301246 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hubei Hongyuan Pharmaceutical Technology Co Ltd Insider Transactions
No Available Data